Nomura Holdings’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-23,578
Closed -$34K 1611
2025
Q1
$34K Sell
23,578
-42
-0.2% -$77 ﹤0.01% 1707
2024
Q4
$52K Buy
23,620
+42
+0.2% +$98 ﹤0.01% 2120
2024
Q3
$38.9K Hold
23,578
﹤0.01% 1471
2024
Q2
$52.3K Hold
23,578
﹤0.01% 1707
2024
Q1
$63.2K Sell
23,578
-13,767
-37% -$33.5K ﹤0.01% 1537
2023
Q4
$112K Sell
37,345
-78,676
-68% -$102K ﹤0.01% 1653
2023
Q3
$114K Hold
116,021
﹤0.01% 1273
2023
Q2
$161K Hold
116,021
﹤0.01% 1181
2023
Q1
$184K Sell
116,021
-73,278
-39% -$378K ﹤0.01% 1245
2022
Q4
$1.17M Buy
+189,299
New +$1.35M ﹤0.01% 817
2021
Q4
Sell
-31,045
Closed -$369K 2308
2021
Q3
$369K Sell
31,045
-57,563
-65% -$838K ﹤0.01% 1528
2021
Q2
$1.88M Buy
88,608
+17,081
+24% +$411K ﹤0.01% 890
2021
Q1
$2M Sell
71,527
-217,291
-75% -$6.41M ﹤0.01% 865
2020
Q4
$7.53M Buy
288,818
+63,818
+28% +$1.91M 0.01% 489
2020
Q3
$8.36M Hold
225,000
0.02% 388
2020
Q2
$11.6M Hold
225,000
0.04% 243
2020
Q1
$7.08M Sell
225,000
-325,000
-59% -$17.2M 0.03% 290
2019
Q4
$32.7M Hold
550,000
0.12% 131
2019
Q3
$19.8M Hold
550,000
0.07% 201
2019
Q2
$25.1M Hold
550,000
0.11% 155
2019
Q1
$22M Buy
550,000
+85,300
+18% +$3.83M 0.09% 168
2018
Q4
$21.3M Buy
464,700
+184,700
+66% +$8.9M 0.08% 187
2018
Q3
$12.7M Buy
280,000
+30,000
+12% +$1.38M 0.04% 315
2018
Q2
$9.8M Buy
250,000
+245,000
+4,900% +$12.4M 0.03% 372
2018
Q1
$362 Buy
+5,000
New +$367K ﹤0.01% 1259

Other funds holding ESPR